BlossomHill Therapeutics Inc

NAS:BLSMHealth Technologynasdaq_composite

——At close · Market cap — · Next earnings Wed 2 Dec

USD millions	FY2024	FY2025
Revenue	0.0	0.0
Cost of revenue	0.4	0.4
Gross profit	(0.4)	(0.4)
Research & development	31.8	56.1
Operating expenses	36.1	63.6
Operating income	(36.4)	(64.0)
Interest income	5.7	3.5
Pre-tax income	(30.7)	(60.6)
Income tax	0.0	0.0
Net income	(30.7)	(60.6)
EPS, basic (per share)	(0.97)	(1.91)
EPS, diluted (per share)	(0.97)	(1.91)
EBITDA	(36.1)	(63.6)
Depreciation & amortization	0.4	0.4
Weighted average shares (shares)	31,784,909	31,784,909
Weighted average diluted shares (shares)	31,784,909	31,784,909

USD millionsUpdated Fri 18 Sep ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.